Pascal Druzgala, Ph.D., Co-founder & Director

Dr. Druzgala is a co-founder and has been serving on our board since July 2007. He is an experienced entrepreneur and drug design expert. He co-founded ARYx Therapeutics (NASDAQ: ARYX) where he has been serving as Senior Vice President and Chief Scientific Officer since 1997, responsible for all research related activities. Prior to ARYx, he also co-founded Advanced Therapies, Inc., a biopharmaceutical company. Dr. Druzgala is an expert in drug design and discovery and he has brought numerous drugs to clinical phase, including drugs that are presently marketed. He authored or co-authored numerous issued patents and scientific articles.

Dr. Druzgala received a Pharm.D degree from the University of Montpellier, France, and then earned his diplôme d’études approfondies degree at the European Institute of Industrial Pharmaceutical Sciences in Montpellier, France. Dr. Druzgala later graduated from the University of Florida with a doctorate in medicinal chemistry. He completed his post doctorate work at the Center for Drug Design and Discovery at the University of Florida.